Details of the Drug Formulations

General Information of Drug (ID: DMRF9YK)

Drug Name
Empagliflozin Drug Info
Synonyms
864070-44-0; JARDIANCE; BI 10773; UNII-HDC1R2M35U; Empagliflozin (BI 10773); BI-10773; BI10773; HDC1R2M35U; CHEBI:82720; 1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene; AK160980; (1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol; (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Indication
Disease Entry ICD 11 Status REF
Type-1 diabetes 5A10 Approved [1]
Cross-matching ID
PubChem CID
11949646
ChEBI ID
CHEBI:82720
CAS Number
864070-44-0
TTD ID
D06ALD
VARIDT ID
DR00271
INTEDE ID
DR1755
ACDINA ID
D01043

Full List of Drug Formulations Containing This Drug

Empagliflozin 10mg tablet
Company Formulation ID FDA Description
Boehringer Ingelheim F24054 Lactose Monohydrate; Microcrystalline Cellulose; Hydroxypropyl Cellulose; Croscarmellose Sodium; Colloidal Silicon Dioxide; Magnesium Stearate; Hypromellose; Titanium Dioxide; Talc; Polyethylene Glycol; Yellow Ferric Oxide
------------------------------------------------------------------------------------
Empagliflozin 25mg tablet
Company Formulation ID FDA Description
Boehringer Ingelheim F24055 Lactose Monohydrate; Microcrystalline Cellulose; Hydroxypropyl Cellulose; Croscarmellose Sodium; Colloidal Silicon Dioxide; Magnesium Stearate; Hypromellose; Titanium Dioxide; Talc; Polyethylene Glycol; Yellow Ferric Oxide
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4754).